Literature DB >> 22210740

Minireview: Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior.

Boris B Gorzalka1, Silvain S Dang.   

Abstract

Endocannabinoids act as a major neuromodulatory system in a variety of physiological and behavioral functions. Three major lines of evidence suggest that the endocannabinoid system interacts with gonadal hormones. First, the endocannabinoid system is implicated in behaviors and physiological functions that are known to be regulated in part by gonadal hormones. Second, receptors and metabolic enzymes of the endocannabinoid system are localized extensively on structures in the hypothalamic-pituitary-gonadal axis. Third, changes in levels of gonadal hormones alter endocannabinoid signaling. Here we reviewed and summarized the current evidence regarding the interaction between the endocannabinoid system and androgens, estrogens, and progesterone. Overall, it appears that bidirectional interactions characterize the relationship between endocannabinoids and gonadal hormones, with endocannabinoids down-regulating hypothalamic-pituitary-gonadal activity and gonadal hormones modulating protein expression in the endocannabinoid system. An understanding of these interactions will have implications for elucidating the neuroendocrine mechanisms underlying a number of behavioral and physiological functions as well as potential pharmaceutical treatments for disorders of these functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210740     DOI: 10.1210/en.2011-1643

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

Review 1.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

2.  Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Behav Brain Res       Date:  2015-12-09       Impact factor: 3.332

Review 3.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

Review 4.  The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development.

Authors:  Heidi C Meyer; Francis S Lee; Dylan G Gee
Journal:  Neuropsychopharmacology       Date:  2017-07-07       Impact factor: 7.853

Review 5.  Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications.

Authors:  Yvonne M Ulrich-Lai; Karen K Ryan
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

6.  Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol.

Authors:  Nicola Bernabò; Barbara Barboni; Mauro Maccarrone
Journal:  OMICS       Date:  2013-10-11

7.  Chronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques.

Authors:  Angela M Amedee; Whitney A Nichols; Nicole J LeCapitaine; Curtis Vande Stouwe; Leslie L Birke; Nedra Lacour; Peter J Winsauer; Patricia E Molina
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

8.  Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males.

Authors:  Corinde E Wiers; Ehsan Shokri-Kojori; Christopher T Wong; Anissa Abi-Dargham; Şükrü B Demiral; Dardo Tomasi; Gene-Jack Wang; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2016-05-09       Impact factor: 7.853

9.  Chronic administration during early adulthood does not alter the hormonally-dependent disruptive effects of delta-9-tetrahydrocannabinol (Δ9-THC) on complex behavior in female rats.

Authors:  Peter J Winsauer; Jessie L Sutton
Journal:  Pharmacol Biochem Behav       Date:  2013-12-18       Impact factor: 3.533

10.  Is cannabis a risk factor for suicide attempts in men and women with psychotic illness?

Authors:  A Waterreus; P Di Prinzio; J C Badcock; M Martin-Iverson; A Jablensky; V A Morgan
Journal:  Psychopharmacology (Berl)       Date:  2018-05-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.